Safety and efficacy of autologous tumour cell vaccines as a cancer therapeutic to treat solid tumours and haematological malignancies: a meta-analysis protocol for two systematic reviews

INTRODUCTION: Autologous cancer cell vaccines are promising personalised immunotherapeutic options for solid and haematological malignancies that uses the patient’s own cells to arm an immune response. Evidence suggests that among patients receiving these vaccines, those who mount an immune response...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Sarwat T, Montroy, Joshua, Forbes, Nicole, Bastin, Donald, Kennedy, Michael A, Diallo, Jean-Simon, Kekre, Natasha, Fergusson, Dean A, Lalu, Manoj, Auer, Rebecca C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282323/
https://www.ncbi.nlm.nih.gov/pubmed/32518209
http://dx.doi.org/10.1136/bmjopen-2019-034714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282323/
https://www.ncbi.nlm.nih.gov/pubmed/32518209
http://dx.doi.org/10.1136/bmjopen-2019-034714

Ejemplares similares